New York, NY, United States of America

Ohr Pharmaceutical Inc.


USPTO Granted Patents = 6



Forward Citations = 12

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Michael McLane (5 out of 12 patents)

silverMedal Inez Ruiz-White (3 out of 5 patents)

bronzeMedal Henry Raphael Wolfe (3 out of 14 patents)

4 W Lee Maloy (2 out of 18 patents)

5 Xuehai Zhang (2 out of 3 patents)

6 William Alvin Kinney (2 out of 65 patents)

7 Roy C Levitt, Jr (1 out of 3 patents)

8 Mark L Anderson (1 out of 69 patents)

9 Eric Chellquist (1 out of 1 patent)

10 Mary Doubleday (1 out of 1 patent)

11 Charles W Gilbert (1 out of 1 patent)

12 Kyle Armbruster (1 out of 1 patent)

13 Ronald Stanley Michalak (1 out of 13 patents)

14 Jon I Williams (1 out of 15 patents)

15 Michael A Zasloff (1 out of 55 patents)


6 patents:

Ohr Pharmaceutical Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for ophthalmic diseases. The company's lead product candidate, Squalamine eye drops, is currently in Phase 3 clinical trials for the treatment of wet age-related macular degeneration. Ohr Pharmaceuticals is committed to advancing innovative treatments to improve the lives of patients with eye disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
6 Patents

#946 in New York, NY

#2,570 in New York

#43,751 in US

...
New York, NY, United States of America
Forward Citations = 12

15 inventors:

Please report any incorrect information to support@idiyas.com
Loading…